R. M. Abra and C. A. Hunt, Liposome disposition in vivo. III. Dose and vesiclesize effects, Biochim. Biophys. Acta, vol.666, pp.493-503, 1981.

H. Abrahamse and M. R. Hamblin, New photosensitizers for photodynamic therapy, Biochem. J, vol.473, pp.347-364, 2016.

H. Agashe, K. Sahoo, P. Lagisetty, A. , and V. , Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats, Colloids Surf. B Biointerfaces, vol.84, pp.329-337, 2011.

P. Agostinis, E. Buytaert, H. Breyssens, and N. Hendrickx, Regulatory pathways in photodynamic therapy induced apoptosis, Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol, vol.3, pp.721-729, 2004.

P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti et al., Photodynamic therapy of cancer: An update. CA, Cancer J. Clin, vol.61, pp.250-281, 2011.

A. Akbarzadeh, R. Rezaei-sadabady, S. Davaran, S. W. Joo, N. Zarghami et al., Liposome: classification, preparation, and applications, Nanoscale Res. Lett, vol.8, p.102, 2013.

R. R. Allison and C. H. Sibata, Oncologic photodynamic therapy photosensitizers: a clinical review, Photodiagnosis Photodyn. Ther, vol.7, pp.61-75, 2010.

R. D. Almeida, B. J. Manadas, A. P. Carvalho, and C. B. Duarte, Intracellular signaling mechanisms in photodynamic therapy, Biochim. Biophys. Acta, vol.1704, pp.59-86, 2004.

G. Angelini, C. Campestre, S. Boncompagni, and C. Gasbarri, Liposomes entrapping ?-cyclodextrin/ibuprofen inclusion complex: Role of the host and the guest on the bilayer integrity and microviscosity, Chem. Phys. Lipids, vol.209, pp.61-65, 2017.

G. Antlsperger and G. Schmid, Toxicological Comparison of Cyclodextrins, Proceedings of the Eighth International Symposium on Cyclodextrins, J. Szejtli, and L, 1996.

. Szente, , pp.149-155

H. Arima, Y. Hagiwara, F. Hirayama, and K. Uekama, Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes, J. Drug Target, vol.14, pp.225-232, 2006.

H. Arima, K. Motoyama, and T. Irie, Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, pp.91-122, 2011.

R. Arun and S. C. Ashok-k, Cyclodextrins as Drug Carrier Molecule: A Review, Sci. Pharm, vol.76, pp.567-598, 2008.

A. Ascenso, M. Cruz, C. Euletério, F. A. Carvalho, N. C. Santos et al., Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach, J. Liposome Res, vol.23, pp.211-219, 2013.

S. G. Awuah and Y. You, Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy, RSC Adv, vol.2, pp.11169-11183, 2012.

D. J. Ball, D. I. Vernon, and S. B. Brown, The high photoactivity of m-THPC in photodynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture, Photochem. Photobiol, vol.69, pp.360-363, 1999.

A. D. Bangham and R. W. Horne, Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope, J. Mol. Biol, vol.8, pp.660-670, 1964.

A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids, J. Mol. Biol, vol.13, pp.238-265, 1965.

Y. Barenholz, Doxil®--the first FDA-approved nano-drug: lessons learned, J. Control. Release Off. J. Control. Release Soc, vol.160, pp.117-134, 2012.

R. Baskaran, J. Lee, Y. , and S. , Clinical development of photodynamic agents and therapeutic applications, Biomater. Res, vol.22, 2018.

M. Battaglia-parodi, C. La-spina, L. Berchicci, G. Petruzzi, and F. Bandello, , 2016.

P. Photosensitizers and . Therapy, Verteporfin. Dev. Ophthalmol, vol.55, pp.330-336

A. Bautista-sanchez, A. Kasselouri, M. Desroches, J. Blais, and P. Maillard,

D. M. Oliveira, A. C. Tedesco, P. Prognon, and J. Delaire, Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins, J. Photochem. Photobiol. B, vol.81, pp.154-162, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00016449

A. Ben-mihoub, L. Larue, A. Moussaron, Z. Youssef, L. Colombeau et al., Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment, Molecules, vol.23, 1936.
URL : https://hal.archives-ouvertes.fr/hal-02058223

M. C. Berenbaum, S. L. Akande, R. Bonnett, H. Kaur, S. Ioannou et al., meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity, Br. J. Cancer, vol.54, pp.717-725, 1986.

J. Berlanda, T. Kiesslich, V. Engelhardt, B. Krammer, and K. Plaetzer, , 2010.

, Comparative in vitro study on the characteristics of different photosensitizers employed in PDT, J. Photochem. Photobiol. B, vol.100, pp.173-180

C. S. Betz, W. Rauschning, E. P. Stranadko, M. V. Riabov, V. N. Volgin et al., Long-term outcomes following Foscan®-PDT of basal cell carcinomas, Lasers Surg. Med, vol.44, pp.533-540, 2012.

W. Beyer, Systems for light application and dosimetry in photodynamic therapy, 1996.

, J. Photochem. Photobiol. B, vol.36, pp.153-156

P. Bhatt, R. Lalani, I. Vhora, S. Patil, J. Amrutiya et al., , 2018.

, Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation, Int. J. Pharm, vol.536, pp.95-107

J. Bizik, E. Kankuri, A. Ristimäki, A. Taïeb, H. Vapaatalo et al., Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression, Cell Death Differ, vol.11, pp.183-195, 2004.

J. Blanchard and S. Proniuk, Some important considerations in the use of cyclodextrins, Pharm. Res, vol.16, pp.1796-1798, 1999.

R. Bonnett, R. D. White, U. J. Winfield, and M. C. Berenbaum, Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers, Biochem. J, vol.261, pp.277-280, 1989.

R. Bonnett, P. Charlesworth, B. D. Djelal, S. Foley, D. J. Mcgarvey et al., Photophysical properties of 5, 20-tetrakis(m-hydroxyphenyl)porphyrin (m-THPP), 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC) and 5,10,15,20-tetrakis(m-References hydroxyphenyl)bacteriochlorin (m-THPBC): a comparative study, vol.10, pp.325-328, 1999.

S. G. Bown, A. Z. Rogowska, D. E. Whitelaw, W. R. Lees, L. B. Lovat et al., Photodynamic therapy for cancer of the pancreas, Gut, vol.50, pp.549-557, 2002.

M. Bragagni, F. Maestrelli, N. Mennini, C. Ghelardini, and P. Mura, , 2010.

, Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ßcyclodextrin on drug anesthetic efficacy, J. Liposome Res, vol.20, pp.315-322

H. Cai, Q. Wang, J. Luo, and C. K. Lim, (m-hydroxyphenyl)chlorin in rats and humans, Biomed. Chromatogr, vol.5, pp.184-186, 1999.

H. Cai, Q. Wang, J. Luo, and C. K. Lim, Study of temoporfin metabolism by HPLC and electrospray mass spectrometry, Biomed. Chromatogr. BMC, vol.13, pp.354-359, 1999.

G. A. Campbell, K. E. Bartels, C. Arnold, T. Healey, R. L. Cowell et al., Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat, Lasers Med. Sci, vol.17, pp.79-85, 2002.

S. B. Carneiro, F. Í. Duarte, L. Heimfarth, J. Quintans, S. S. De et al., Cyclodextrin-Drug Inclusion Complexes: In Vivo and In Vitro Approaches, Int. J. Mol. Sci, vol.20, 2019.

A. P. Castano, T. N. Demidova, and M. R. Hamblin, Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization, Photodiagnosis Photodyn. Ther, vol.1, pp.279-293, 2004.

A. P. Castano, T. N. Demidova, and M. R. Hamblin, Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death, Photodiagnosis Photodyn. Ther, vol.2, pp.1-23, 2005.

A. P. Castano, P. Mroz, and M. R. Hamblin, Photodynamic therapy and antitumour immunity, Nat. Rev. Cancer, vol.6, pp.535-545, 2006.

M. Castedo, J. Perfettini, T. Roumier, K. Andreau, R. Medema et al., Cell death by mitotic catastrophe: a molecular definition, Oncogene, vol.23, pp.2825-2837, 2004.

I. M. Cavalcanti, E. A. Mendonça, M. C. Lira, S. B. Honrato, and C. A. Camara,

R. V. Amorim, J. Mendes-filho, M. M. Rabello, M. Z. Hernandes, and A. P. Ayala, , 2011.

, The encapsulation of ?-lapachone in 2-hydroxypropyl-?-cyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.44, pp.332-340

R. Challa, A. Ahuja, J. Ali, and R. K. Khar, Cyclodextrins in drug delivery: An updated review, AAPS PharmSciTech, vol.6, pp.329-357, 2005.

H. Chen, J. Gao, F. Wang, and W. Liang, Preparation, Characterization and Pharmacokinetics of Liposomes-Encapsulated Cyclodextrins Inclusion Complexes for Hydrophobic Drugs, Drug Deliv, vol.14, pp.201-208, 2007.

J. Chen, W. Lu, W. Gu, S. Lu, Z. Chen et al., , 2014.

, Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs, Expert Opin. Drug Deliv, vol.11, pp.565-577

K. A. Connors, The Stability of Cyclodextrin Complexes in Solution, Chem. Rev, vol.97, pp.1325-1358, 1997.

S. Coutier, L. N. Bezdetnaya, T. H. Foster, R. Parache, and F. Guillemin, , 2002.

, Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice, Radiat. Res, vol.158, pp.339-345

R. A. Craig, C. P. Mccoy, S. P. Gorman, and D. S. Jones, Photosensitisersthe progression from photodynamic therapy to anti-infective surfaces, Expert Opin. Drug Deliv, vol.12, pp.85-101, 2015.

G. Crini, Review: A History of Cyclodextrins, Chem. Rev, vol.114, pp.10940-10975, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01089582

J. Cui, C. Li, C. Wang, Y. Li, L. Zhang et al., , 2011.

, Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?, J. Pharm. Sci, vol.100, pp.2835-2848

M. D. Daniell and J. S. Hill, A history of photodynamic therapy, Aust. N. Z. J. Surg, vol.61, pp.340-348, 1991.

M. E. Davis and M. E. Brewster, Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug Discov, vol.3, pp.1023-1035, 2004.

A. T. De-bie, B. Van-ommen, and A. Bär, Disposition of [14C]gammacyclodextrin in germ-free and conventional rats, Regul. Toxicol. Pharmacol. RTP, vol.27, pp.150-158, 1998.

D. Valle and E. M. , Cyclodextrins and their uses: a review, Process Biochem, vol.39, pp.1033-1046, 2004.

E. Delaey, F. Van-laar, D. De-vos, A. Kamuhabwa, P. Jacobs et al., A comparative study of the photosensitizing characteristics of some cyanine dyes, J. Photochem. Photobiol. B, vol.55, pp.27-36, 2000.

S. Deljoo, N. Rabiee, R. , and M. , Curcumin-hybrid Nanoparticles in Drug Delivery System (Review), Asian J. Nanosci. Mater, vol.2, pp.66-91, 2019.

M. Desroches, A. Kasselouri, O. Bourdon, P. Chaminade, J. Blais et al., A direct sensitized fluorimetric determination of5,10,15,20-tetra(mhydroxyphenyl)chlorin [m-THPC(Foscan)®] in human plasma using a cyclodextrin inclusion complex, Analyst, vol.126, pp.923-927, 2001.

M. Dewaele, H. Maes, A. , and P. , ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy, Autophagy, vol.6, pp.838-854, 2010.

S. S. Dhule, P. Penfornis, T. Frazier, R. Walker, J. Feldman et al., Curcumin-loaded ?-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma, Nanomedicine Nanotechnol. Biol. Med, vol.8, pp.440-451, 2012.

I. Diamond, A. Mcdonagh, C. Wilson, S. Granelli, S. Nielsen et al., PHOTODYNAMIC THERAPY OF MALIGNANT TUMOURS. The Lancet, vol.300, pp.1175-1177, 1972.

D. E. Dolmans, D. Fukumura, and R. K. Jain, Photodynamic therapy for cancer, Nat. Rev. Cancer, vol.3, pp.380-387, 2003.

D. Santos, A. F. De-almeida, D. R. Terra, L. F. Baptista, M. S. Labriola et al., Photodynamic therapy in cancer treatment -an update review, J. Cancer Metastasis Treat, p.25, 2019.

T. J. Dougherty, An update on photodynamic therapy applications, J. Clin. Laser Med. Surg, vol.20, pp.3-7, 2002.

D. Duchêne, Cyclodextrins and Their Inclusion Complexes, Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, pp.1-18, 2011.

J. S. Dysart and M. S. Patterson, Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cellsin vitro, Phys. Med. Biol, vol.50, pp.2597-2616, 2005.

A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K. H. Plate et al., Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies, Cancer Res, vol.60, pp.1388-1393, 2000.

V. Ellerkamp, N. Bortel, E. Schmid, B. Kirchner, S. Armeanu-ebinger et al., Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells, Anticancer Res, vol.36, pp.3363-3372, 2016.

D. G. Fatouros, K. Hatzidimitriou, and S. G. Antimisiaris, Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release, Eur. J. Pharm. Sci, vol.13, pp.287-296, 2001.

V. H. Fingar, S. W. Taber, P. S. Haydon, L. T. Harrison, S. J. Kempf et al., Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville, Vivo Athens Greece, vol.14, pp.93-100, 2000.

S. Fitzmaurice and D. B. Eisen, Daylight Photodynamic Therapy: What is Known and What is Yet to be Determined, Dermatol. Surg. Off. Publ. Am. Soc. Dermatol. Surg. Al, vol.42, pp.286-295, 2016.

T. P. Forsyth, D. J. Nurco, . Pandey, K. Ravindra, and K. M. Smith, Synthesis and structure of a 5,15-bis(4-pyridyl)purpurin, Tetrahedron Lett, vol.36, pp.9093-9096, 1995.

D. W. Frank, J. E. Gray, and R. N. Weaver, Cyclodextrin nephrosis in the rat, Am. J. Pathol, vol.83, pp.367-382, 1976.

S. Franzè, U. M. Musazzi, P. Minghetti, and F. Cilurzo, Drug-in-micelles-inliposomes (DiMiL) systems as a novel approach to prevent drug leakage from deformable liposomes, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.130, pp.27-35, 2019.

K. Frömming and J. Szejtli, Cyclodextrins in Pharmacy, 1994.

E. Gaio, D. Scheglmann, E. Reddi, and F. Moret, Uptake and photo-toxicity of, 2016.

. Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids, J. Photochem. Photobiol. B, vol.161, pp.244-252

A. D. Garg, D. V. Krysko, P. Vandenabeele, A. , and P. , Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin, Cancer Immunol. Immunother, vol.61, pp.215-221, 2012.

J. Garrier, A. Bressenot, S. Gräfe, S. Marchal, S. Mitra et al., Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis, Int. J. Radiat. Oncol. Biol. Phys, vol.78, pp.563-571, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00479855

I. P. Van-geel, H. Oppelaar, Y. G. Oussoren, M. A. Van-der-valk, and F. A. Stewart, Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin, Int. J. Cancer, vol.60, pp.388-394, 1995.

A. Gerloczy, S. Antal, I. Szathmari, R. Muller-horvath, and J. Szejtli, , 1990.

, Absorption, distribution and excretion of 14C-labelled hydroxypropyl ?cyclodextrin in rats following oral administration, Minutes 5th Int. Symp. Cyclodext. ParisMarch, pp.507-520, 1990.

S. Paris,

R. Gharib, H. Greige-gerges, S. Fourmentin, C. Charcosset, A. et al., Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge, Carbohydr. Polym, vol.129, pp.175-186, 2015.

R. Gharib, H. Greige-gerges, A. Jraij, L. Auezova, and C. Charcosset, , 2016.

, Preparation of drug-in-cyclodextrin-in-liposomes at a large scale using a membrane contactor: Application to trans-anethole, Carbohydr. Polym, vol.154, pp.276-286

B. Gidwani and A. Vyas, A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs, BioMed Res. Int, 2015.

A. Gillet, A. Grammenos, P. Compère, B. Evrard, and G. Piel, Development of a new topical system: Drug-in-cyclodextrin-in-deformable liposome, Int. J. Pharm, vol.380, pp.174-180, 2009.

T. Glanzmann, C. Hadjur, M. Zellweger, P. Grosiean, M. Forrer et al., Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy, Photochem. Photobiol, vol.67, pp.596-602, 1998.

S. O. Gollnick, L. Vaughan, and B. W. Henderson, Generation of effective antitumor vaccines using photodynamic therapy, Cancer Res, vol.62, pp.1604-1608, 2002.

K. Gotoh, R. Kariya, M. M. Alam, K. Matsuda, S. Hattori et al., The antitumor effects of methyl-?-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts, Biochem. Biophys. Res. Commun, vol.455, pp.285-289, 2014.

S. Gould and R. C. Scott, 2-Hydroxypropyl-?-cyclodextrin (HP-?-CD): A toxicology review, Food Chem. Toxicol, vol.43, pp.1451-1459, 2005.

G. Gregoriadis, E. J. Wills, C. P. Swain, and A. S. Tavill, Drug-carrier potential of liposomes in cancer chemotherapy, Lancet Lond. Engl, vol.1, pp.1313-1316, 1974.

P. Y. Grosse, F. Bressolle, and F. Pinguet, Antiproliferative effect of methylbeta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice, Br. J. Cancer, vol.78, pp.1165-1169, 1998.

M. Guardiano, R. Biolo, G. Jori, and K. Schaffner, Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice, Cancer Lett, vol.44, pp.1-6, 1989.

M. Gulati, M. Grover, S. Singh, and M. Singh, Lipophilic drug derivatives in liposomes, Int. J. Pharm, vol.165, pp.129-168, 1998.

Z. Hammoud, N. Khreich, L. Auezova, S. Fourmentin, A. Elaissari et al., Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance, Int. J. Pharm, vol.564, pp.59-76, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02092355

A. Hansch, O. Frey, M. Gajda, G. Susanna, J. Boettcher et al., Photodynamic treatment as a novel approach in the therapy of arthritic joints, Lasers Surg. Med, vol.40, pp.265-272, 2008.

P. Hatzi, S. Mourtas, G. Klepetsanis, P. Antimisiaris, and S. G. , Integrity of liposomes in presence of cyclodextrins: Effect of liposome type and lipid composition, Int. J. Pharm, vol.333, pp.167-176, 2007.

B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol, vol.55, pp.145-157, 1992.

B. W. Henderson, S. M. Waldow, T. S. Mang, W. R. Potter, P. B. Malone et al., Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy, Cancer Res, vol.45, pp.572-576, 1985.

B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis et al., Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors, Cancer Res, vol.64, pp.2120-2126, 2004.

R. K. Horlings, J. B. Terra, and M. J. Witjes, mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review, Lasers Surg. Med, vol.47, pp.779-787, 2015.

T. Irie and K. Uekama, Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation, J. Pharm. Sci, vol.86, pp.147-162, 1997.

T. Ishida, M. Harada, X. Y. Wang, M. Ichihara, K. Irimura et al., , 2005.

, Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes, J. Control. Release Off. J. Control. Release Soc, vol.105, pp.305-317

L. Jablonka, M. Ashtikar, G. Gao, F. Jung, M. Thurn et al., Advanced in silico modeling explains pharmacokinetics and biodistribution of temoporfin nanocrystals in humans, J. Controlled Release, vol.308, pp.57-70, 2019.

S. Jain, D. G. Hirst, and J. M. Sullivan, Gold nanoparticles as novel agents for cancer therapy, Br. J. Radiol, vol.85, pp.101-113, 2012.

S. K. Jain, Y. Gupta, A. Jain, and M. Bhola, Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery, Drug Deliv, vol.14, pp.327-335, 2007.

T. J. Jensen, M. G. Vicente, R. Luguya, J. Norton, F. R. Fronczek et al., Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells, J. Photochem. Photobiol. B, vol.100, pp.100-111, 2010.

W. Jerjes, T. Upile, Z. Hamdoon, C. Alexander-mosse, M. Morcos et al., References dehydrocrotonin in liposomes: an enhancement of the antitumor activity, J. Biomed. Nanotechnol, vol.43, pp.499-510, 2011.

H. Lassalle, M. Wagner, L. Bezdetnaya, F. Guillemin, and H. Schneckenburger,

, Fluorescence imaging of Foscan® and Foslip in the plasma membrane and in whole cells, J. Photochem. Photobiol. B, vol.92, pp.47-53

A. L. Laza-knoerr, R. Gref, and P. Couvreur, Cyclodextrins for drug delivery, J. Drug Target, vol.18, pp.645-656, 2010.

M. Leist, J. , and M. , Triggering of apoptosis by cathepsins, Cell Death Differ, vol.8, pp.324-326, 2001.

T. Loftsson and M. E. Brewster, , 1996.

, Drug solubilization and stabilization, J. Pharm. Sci, vol.85, pp.1017-1025

T. Loftsson and M. E. Brewster, Pharmaceutical applications of cyclodextrins: basic science and product development, J. Pharm. Pharmacol, vol.62, pp.1607-1621, 2010.

T. Loftsson and M. E. Brewster, Drug Solubilization and Stabilization by Cyclodextrin Drug Carriers, Drug Delivery Strategies for Poorly Water-Soluble Drugs, pp.67-101, 2013.

T. Loftsson and D. Duchene, Cyclodextrins and their pharmaceutical applications, Int. J. Pharm, vol.329, pp.1-11, 2007.

T. Loftsson, M. Másson, and M. E. Brewster, Self-association of cyclodextrins and cyclodextrin complexes, J. Pharm. Sci, vol.93, pp.1091-1099, 2004.

J. M. López-pinto, M. L. González-rodríguez, and A. M. Rabasco, Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes, Int. J. Pharm, vol.298, pp.1-12, 2005.

S. S. Lucky, K. C. Soo, and Y. Zhang, Nanoparticles in Photodynamic Therapy, Chem. Rev, vol.115, pp.1990-2042, 2015.

D. H. Lynch, S. Haddad, V. J. King, M. J. Ott, R. C. Straight et al., , 1989.

, Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages, Photochem. Photobiol, vol.49, pp.453-458

L. W. Ma, E. Bjørklund, and J. Moan, Photochemotherapy of tumours with mesotetrahydroxyphenyl chlorin is pH dependent, Cancer Lett, vol.138, pp.197-201, 1999.

I. J. Macdonald and T. J. Dougherty, Basic principles of photodynamic therapy, 2001.

, J. Porphyr. Phthalocyanines, vol.5, pp.105-129

H. Maeda, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul, vol.41, pp.189-207, 2001.

F. Maestrelli, M. L. González-rodríguez, A. M. Rabasco, and P. Mura, , 2005.

, Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery, Int. J. Pharm, vol.298, pp.55-67

F. Maestrelli, M. L. González-rodríguez, A. M. Rabasco, and P. Mura, Effect of preparation technique on the properties of liposomes encapsulating ketoprofencyclodextrin complexes aimed for transdermal delivery, Int. J. Pharm, vol.312, pp.53-60, 2006.

F. Maestrelli, M. L. González-rodríguez, A. M. Rabasco, C. Ghelardini, and P. Mura, New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics, Int. J. Pharm, vol.395, pp.222-231, 2010.

D. Magda and R. A. Miller, Motexafin gadolinium: A novel redox active drug for cancer therapy, Semin. Cancer Biol, vol.16, pp.466-476, 2006.

S. Marchal, L. Bezdetnaya, and F. Guillemin, Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29, Biochem. Biokhimii ? a ?, vol.69, pp.45-49, 2004.

S. Marchal, A. Fadloun, E. Maugain, M. D'hallewin, F. Guillemin et al., Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids, Biochem. Pharmacol, vol.69, pp.1167-1176, 2005.

S. Marchal, A. François, D. Dumas, F. Guillemin, and L. Bezdetnaya, , 2007.

, Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells, Br. J. Cancer, vol.96, pp.944-951

S. Marchal, A. El-hor, M. Millard, V. Gillon, and L. Bezdetnaya, Anticancer Drug Delivery: An Update on, Clinically Applied Nanotherapeutics. Drugs, vol.75, pp.1601-1611, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01215444

Y. Matoba, K. Banno, I. Kisu, and D. Aoki, Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review, Photodiagnosis Photodyn. Ther, vol.24, pp.52-57, 2018.

Y. Matsumura and H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res, vol.46, pp.6387-6392, 1986.

B. Mccormack and G. Gregoriadis, Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery, J. Drug Target, vol.2, pp.449-454, 1994.

B. Mccormack and G. Gregoriadis, Drugs-in-cyclodextrins-in-liposomes: an approach to controlling the fate of water insoluble drugs in vivo, Int. J. Pharm, vol.162, pp.59-69, 1998.

V. O. Melnikova, L. N. Bezdetnaya, C. Bour, E. Festor, M. P. Gramain et al., Subcellular localization of meta-tetra (hydroxyphenyl) chlorin in human tumor cells subjected to photodynamic treatment, J. Photochem. Photobiol. B, vol.49, pp.96-103, 1999.

E. A. Mendonça, M. C. Lira, M. M. Rabello, I. M. Cavalcanti, S. L. Galdino et al., Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes, AAPS PharmSciTech, vol.13, pp.1355-1366, 2012.

N. Mennini, M. Cirri, F. Maestrelli, and P. Mura, Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation, Int. J. Pharm, vol.515, pp.684-691, 2016.

Y. Miki, J. Akimoto, M. Hiranuma, and Y. Fujiwara, Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells, J. Toxicol. Sci, vol.39, pp.821-827, 2014.

M. Millard, I. Yakavets, M. Piffoux, A. Brun, F. Gazeau et al., mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors, Drug Deliv, vol.25, pp.1790-1801, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01996795

J. D. Miller, E. D. Baron, H. Scull, A. Hsia, J. C. Berlin et al., Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies, Toxicol. Appl. Pharmacol, vol.224, pp.290-299, 2007.

S. Mitra and T. H. Foster, Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin, Photochem. Photobiol, vol.81, pp.849-859, 2005.

S. Mitra, E. Maugain, L. Bolotine, F. Guillemin, and T. H. Foster, Temporally and spatially heterogeneous distribution of mTHPC in a murine tumor observed by two-color confocal fluorescence imaging and spectroscopy in a whole-mount model, Photochem. Photobiol, vol.81, pp.1123-1130, 2005.

J. Moan, K. Berg, E. Kvam, A. Western, Z. Malik et al., Intracellular localization of photosensitizers, Ciba Found. Symp, vol.146, pp.107-111, 1989.

N. Mohammad, P. Malvi, A. S. Meena, S. V. Singh, B. Chaube et al., Cholesterol depletion by methyl-?-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma, Mol. Cancer, vol.13, p.204, 2014.

G. Mosher and D. O. Thompson, Complexation: Cyclodextrins, Encyclopedia of Pharmaceutical Technology, pp.671-696, 2007.

L. A. Muehlmann, M. C. Rodrigues, J. P. Longo, M. P. Garcia, K. R. Py-daniel et al., Aluminiumphthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells, J. Nanobiotechnology, vol.13, pp.2225-2238, 2015.

A. E. O'connor, W. M. Gallagher, and A. T. Byrne, Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy, Photochem. Photobiol, vol.85, pp.1053-1074, 2009.

N. L. Oleinick, R. L. Morris, and I. Belichenko, The role of apoptosis in response to photodynamic therapy: what, where, why, and how, Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol, vol.1, pp.1-21, 2002.

T. O. Olusanya, R. R. Haj-ahmad, D. M. Ibegbu, J. R. Smith, and A. A. Elkordy,

A. Oniszczuk, K. A. Wojtunik-kulesza, T. Oniszczuk, and K. Kasprzak, The potential of photodynamic therapy (PDT)-Experimental investigations and clinical use, Liposomal Drug Delivery Systems and Anticancer Drugs, vol.23, pp.912-929, 2016.

R. Onodera, K. Motoyama, A. Okamatsu, T. Higashi, A. et al., , 2013.

, Potential use of Folate-appended Methyl-?-Cyclodextrin as an, Anticancer Agent. Sci. Rep, vol.3

A. B. Ormond and H. S. Freeman, Dye Sensitizers for Photodynamic Therapy, Materials, vol.6, pp.817-840, 2013.

A. Ossmann, S. Kranz, G. Andre, A. Völpel, V. Albrecht et al., Photodynamic killing of Enterococcus faecalis in dentinal tubules using mTHPC incorporated in liposomes and invasomes, Clin. Oral Investig, vol.19, pp.373-384, 2015.

E. Panzarini, V. Inguscio, G. M. Fimia, and L. Dini, Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells, PLOS ONE, vol.9, 2014.

G. Piel, M. Piette, V. Barillaro, D. Castagne, B. Evrard et al., , 2006.

, Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics, Int. J. Pharm, vol.312, pp.75-82

N. Plenagl, L. Duse, B. S. Seitz, N. Goergen, S. R. Pinnapireddy et al., Photodynamic therapy -hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity, Drug Deliv, vol.26, pp.23-33, 2019.

B. W. Pogue, R. W. Redmond, N. Trivedi, and T. Hasan, Photophysical Properties of Tin Ethyl Etiopurpurin I (SnET2) and Tin Octaethylbenzochlorin (SnOEBC) in Solution and Bound to Albumin, Photochem. Photobiol, vol.68, pp.809-815, 1998.

P. Temoporfin,

S. K. Pushpan, S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran et al., Porphyrins in photodynamic therapy -a search for ideal photosensitizers, Curr. Med. Chem. Anti-Cancer Agents, vol.2, pp.187-207, 2002.

I. Puskás and F. Csempesz, Influence of cyclodextrins on the physical stability of DPPC-liposomes, Colloids Surf. B Biointerfaces, vol.58, pp.218-224, 2007.

I. Puskás, L. Barcza, L. Szente, and F. Csempesz, Features of the Interaction between Cyclodextrins and Colloidal Liposomes, J. Incl. Phenom. Macrocycl. Chem, vol.54, pp.89-93, 2006.

S. Rahman, S. Cao, K. J. Steadman, M. Wei, and H. S. Parekh, Native and ?cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer, Drug Deliv, vol.19, pp.346-353, 2012.

R. A. Rajewski and V. J. Stella, Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery, J. Pharm. Sci, vol.85, pp.1142-1169, 1996.

A. Reinhard, W. J. Sandborn, H. Melhem, L. Bolotine, M. Chamaillard et al., Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions, Expert Rev. Clin. Immunol, vol.11, pp.637-657, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01215472

M. V. Rekharsky and Y. Inoue, Complexation Thermodynamics of Cyclodextrins, Chem. Rev, vol.98, pp.1875-1918, 1998.

V. Reshetov, V. Zorin, A. Siupa, M. D'hallewin, F. Guillemin et al., Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction, Photochem. Photobiol, vol.88, pp.1256-1264, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00701915

V. Reshetov, H. Lassalle, A. François, D. Dumas, S. Hupont et al., Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo, Int. J. Nanomedicine, vol.8, pp.3817-3831, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00875936

H. Rezzoug, L. Bezdetnaya, O. Merlin, J. L. Guillemin, and F. , , 1998.

, Parameters Affecting Photodynamic Activity of Foscan® or Meta-tetra(hydroxyphenyl)chlorin (mTHPC) In Vitro and In Vivo, Lasers Med. Sci, vol.13, pp.119-125

H. B. Ris, Q. Li, T. Krueger, C. K. Lim, B. Reynolds et al., Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology, Int. J. Cancer, vol.76, pp.872-874, 1998.

C. A. Robertson, D. H. Evans, A. , and H. , Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT, J. Photochem. Photobiol. B, vol.96, pp.1-8, 2009.

A. M. Ronn, M. Nouri, L. A. Lofgren, B. M. Steinberg, A. Westerborn et al., Human tissue levels and plasma pharmacokinetics of temoporfin (Foscan®, mTHPC), Lasers Med. Sci, vol.11, pp.267-272, 1996.

A. M. Ronn, J. Batti, C. J. Lee, D. Yoo, M. E. Siegel et al., Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy, Lasers Surg. Med, vol.20, pp.437-442, 1997.

M. Sachar, K. E. Anderson, and X. Ma, Protoporphyrin IX: the Good, the Bad, and the Ugly, J. Pharmacol. Exp. Ther, vol.356, pp.267-275, 2016.

W. Saenger, Cyclodextrin Inclusion Compounds in Research and Industry, 1980.

, Angew. Chem. Int. Ed. Engl, vol.19, pp.344-362

M. J. Sailor and J. Park, Hybrid nanoparticles for detection and treatment of cancer, Adv. Mater. Deerfield Beach Fla, vol.24, pp.3779-3802, 2012.

A. Samad, Y. Sultana, A. , and M. , Liposomal drug delivery systems: an update review, Curr. Drug Deliv, vol.4, pp.297-305, 2007.

S. Sasnouski, V. Zorin, I. Khludeyev, M. D'hallewin, F. Guillemin et al., Investigation of Foscan interactions with plasma proteins, Biochim. Biophys. Acta, vol.1725, pp.394-402, 2005.

S. Sasnouski, D. Kachatkou, V. Zorin, F. Guillemin, and L. Bezdetnaya, Redistribution of Foscan® from plasma proteins to model membranes, Photochem. Photobiol. Sci, vol.5, pp.770-777, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00101630

J. F. Savary, P. Monnier, C. Fontolliet, J. Mizeret, G. Wagnières et al., Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin, Arch. Otolaryngol. Head Neck Surg, vol.123, pp.162-168, 1997.

E. Schneiderman and A. M. Stalcup, Cyclodextrins: a versatile tool in separation science, J. Chromatogr. B. Biomed. Sci. App, vol.745, pp.83-102, 2000.

M. O. Senge, mTHPC -A drug on its way from second to third generation photosensitizer?, Photodiagnosis Photodyn. Ther, vol.9, pp.170-179, 2012.

M. O. Senge and J. C. Brandt, Temoporfin (Foscan®, 5,10,15,20-tetra(mhydroxyphenyl)chlorin)--a second-generation photosensitizer, Photochem. Photobiol, vol.87, pp.1240-1296, 2011.

M. O. Senge and M. W. Radomski, Platelets, photosensitizers, and PDT, Photodiagnosis Photodyn. Ther, vol.10, pp.1-16, 2013.

M. Shams, B. Owczarczak, P. Manderscheid-kern, D. A. Bellnier, and S. O. Gollnick, Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease, Cancer Immunol. Immunother. CII, vol.64, pp.287-297, 2015.

S. Shimpi, B. Chauhan, and P. Shimpi, Cyclodextrins: application in different routes of drug administration, Acta Pharm. Zagreb Croat, vol.55, pp.139-156, 2005.

C. Shirata, J. Kaneko, Y. Inagaki, T. Kokudo, M. Sato et al., Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress, Sci. Rep, vol.7, 2009.

, Pharmacokinetics and biodistribution of Photolon® (Fotolon®) in intact and tumor-bearing rats, Photodiagnosis Photodyn. Ther, vol.6, pp.97-104

D. W. Siemann, The Unique Characteristics of Tumor Vasculature and Preclinical Evidence for its Selective Disruption by Tumor-Vascular Disrupting Agents, Cancer Treat. Rev, vol.37, pp.63-74, 2011.

N. ?kalko, M. Brandl, M. Be?irevi?-la?an, J. Filipovi?-gr?i?, J. et al., , 1996.

, Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison, Eur. J. Pharm. Sci, vol.4, pp.359-366

M. Slingerland, H. Guchelaar, and H. Gelderblom, Liposomal drug formulations in cancer therapy: 15 years along the road, Drug Discov. Today, vol.17, pp.160-166, 2012.

G. Smith, W. G. Mcgimpsey, M. C. Lynch, I. E. Kochevar, R. et al., , 1994.

, An Efficient Oxygen Independent Two-Photon Photosensitization Mechanism, Photochem. Photobiol, vol.59, pp.135-139

L. X. Song, L. Bai, X. M. Xu, J. He, and S. Z. Pan, Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry, Coord. Chem. Rev, vol.253, pp.1276-1284, 2009.

V. J. Stella and Q. He, Cyclodextrins. Toxicol. Pathol, vol.36, pp.30-42, 2008.

V. J. Stella, V. M. Rao, E. A. Zannou, Z. , and V. , Mechanisms of drug release from cyclodextrin complexes, Adv. Drug Deliv. Rev, vol.36, pp.3-16, 1999.

D. Van-straten, V. Mashayekhi, H. S. De-bruijn, S. Oliveira, R. et al.,

, Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions, Cancers, vol.9

J. Swartling, J. Axelsson, G. Ahlgren, K. M. Kälkner, S. Nilsson et al., System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer, J. Biomed. Opt, vol.15, p.58003, 2010.

J. Swartling, O. V. Höglund, K. Hansson, F. Södersten, J. Axelsson et al., Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model, J. Biomed. Opt, vol.21, p.28002, 2016.

R. M. Szeimies, S. Karrer, C. Abels, P. Steinbach, S. Fickweiler et al., 9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization, J. Photochem. Photobiol. B, vol.34, pp.67-72, 1996.

J. Szejtli, Introduction and General Overview of Cyclodextrin Chemistry, Chem. Rev, vol.98, pp.1743-1754, 1998.

L. Szente, Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development, Adv. Drug Deliv. Rev, vol.36, pp.17-28, 1999.

L. Szente and É. Fenyvesi, Cyclodextrin-Lipid Complexes: Cavity Size Matters, Struct. Chem, vol.28, pp.479-492, 2017.

S. S. Taneja, J. Bennett, J. Coleman, R. Grubb, G. Andriole et al., Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States, J. Urol, vol.196, pp.1096-1104, 2016.

J. P. Tardivo, A. Del-giglio, C. S. De-oliveira, D. S. Gabrielli, H. C. Junqueira et al., Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications, Photodiagnosis Photodyn. Ther, vol.2, pp.175-191, 2005.

M. Teiten, L. Bezdetnaya, P. Morlière, R. Santus, and F. Guillemin, , 2003.

, Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells, Br. J. Cancer, vol.88, pp.146-152

D. O. Thompson, Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals, Crit. Rev. Ther. Drug Carrier Syst, vol.14, pp.1-104, 1997.

P. Thordarson, Determining association constants from titration experiments in supramolecular chemistry, Chem Soc Rev, vol.40, pp.1305-1323, 2011.

A. M. Tikhomirov, &. Shmigol, T. A. Kozhinova, E. A. Kiagova, A. A. Bezdetnaia et al., Investigation of aggregates of dyes by the method of resonance light scattering: correction of spectra, Biofizika, vol.54, pp.824-830, 2009.

V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov, vol.4, pp.145-160, 2005.

V. P. Torchilin, Passive and active drug targeting: drug delivery to tumors as an example, Handb. Exp. Pharmacol, pp.3-53, 2010.

J. Trachtenberg, R. A. Weersink, S. R. Davidson, M. A. Haider, A. Bogaards et al., Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses, BJU Int, vol.102, pp.556-562, 2008.

M. Triesscheijn, M. Ruevekamp, R. Out, T. J. Van-berkel, J. Schellens et al., The pharmacokinetic behavior of the photosensitizer meso-tetrahydroxyphenyl-chlorin in mice and men, Cancer Chemother. Pharmacol, vol.60, pp.113-122, 2007.

B. J. Tromberg, A. Orenstein, S. Kimel, S. J. Barker, J. Hyatt et al., In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy, Photochem. Photobiol, vol.52, pp.375-385, 1990.

O. Trushina, E. Novikova, E. Filonenko, V. Chissov, and G. Vorozhtsov, , 2011.

, Photosens PDT at the treatment of virus-associated precancer and non-invasive cervical cancer, Photodiagnosis Photodyn. Ther, vol.8, p.217

K. Uekama and M. Otagiri, Cyclodextrins in drug carrier systems, Crit. Rev. Ther. Drug Carrier Syst, vol.3, pp.1-40, 1987.

T. Van-hees, G. Piel, B. Evrard, X. Otte, L. Thunus et al., , 1999.

, Application of supercritical carbon dioxide for the preparation of a piroxicam-betacyclodextrin inclusion compound, Pharm. Res, vol.16, pp.1864-1870

B. Van-ommen, A. T. De-bie, and A. Bär, Disposition of 14C-alphacyclodextrin in germ-free and conventional rats, Regul. Toxicol. Pharmacol. RTP, vol.39, issue.1, pp.57-66, 2004.

N. Vanlangenakker, T. Vanden-berghe, D. V. Krysko, and N. Festjens,

P. Vandenabeele, Molecular mechanisms and pathophysiology of necrotic cell death, Curr. Mol. Med, vol.8, pp.207-220, 2008.

R. Veenhuizen, H. Oppelaar, M. Ruevekamp, J. Schellens, O. Dalesio et al., Does tumour uptake of Foscan determine PDT efficacy?, Int. J. Cancer, vol.73, pp.236-239, 1997.

S. Vemuri and C. T. Rhodes, Preparation and characterization of liposomes as therapeutic delivery systems: a review, Pharm. Acta Helv, vol.70, pp.95-111, 1995.

S. A. De-visscher, L. J. Melchers, P. U. Dijkstra, B. Karakullukcu, I. B. Tan et al., mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment, Ann. Surg. Oncol, vol.20, pp.3076-3082, 2013.

A. Vyas, S. Saraf, and S. Saraf, Cyclodextrin based novel drug delivery systems, J. Incl. Phenom. Macrocycl. Chem, vol.62, pp.23-42, 2008.

A. Wagner, U. W. Denzer, D. Neureiter, T. Kiesslich, A. Puespoeck et al., Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study, Hepatol. Baltim. Md, vol.62, pp.1456-1465, 2015.

G. Wagnieres, C. Hadjur, P. Grosjean, D. Braichotte, J. F. Savary et al., Clinical evaluation of the cutaneous phototoxicity of 5, Photochem. Photobiol, vol.10, pp.382-387, 1998.

X. Wang, L. Deng, L. Cai, X. Zhang, H. Zheng et al., Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-?-cyclodextrin-in-liposome, J. Pharm. Sci, vol.100, pp.3357-3364, 2011.

L. Y. Wen, S. Bae, J. H. Do, K. Park, and W. S. Ahn, The effects of photodynamic therapy with Photodithazine on HPV 16 E6/E7 associated cervical cancer model, J. Porphyr. Phthalocyanines, vol.15, pp.174-180, 2011.

C. M. West, D. C. West, S. Kumar, and J. V. Moore, A Comparison of the Sensitivity to Photodynamic Treatment of Endothelial and Tumour Cells in Different Proliferative States, Int. J. Radiat. Biol, vol.58, pp.145-156, 1990.

P. Westermann, T. M. Glanzmann, S. Folli, D. Braichotte, M. Forrer et al., Comparison of the influence of a water-soluble polymer carrier on the tumor localization and biodistribution of mesotetrametahydroxyphenylchlorin (mTHPC) in two animal models, 5th International Photodynamic Association Biennial Meeting, (International Society for Optics and Photonics), pp.45-51, 1995.

R. Whelpton, A. T. Michael-titus, S. S. Basra, and M. Grahn, Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model, Photochem. Photobiol, vol.61, pp.397-401, 1996.

I. Yakavets, I. Yankovsky, L. Bezdetnaya, and V. Zorin, Soret band shape indicates mTHPC distribution between ?-cyclodextrins and serum proteins, Dyes Pigments, vol.137, pp.299-306, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01418967

I. Yakavets, I. Yankovsky, M. Millard, L. Lamy, H. Lassalle et al., The alteration of temoporfin distribution in multicellular tumor spheroids by ?-cyclodextrins, Int. J. Pharm, vol.529, pp.568-575, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01726347

I. Yakavets, H. Lassalle, D. Scheglmann, A. Wiehe, V. Zorin et al., Temoporfin-in-Cyclodextrin-in-Liposome-A New Approach for Anticancer Drug Delivery: The Optimization of Composition, vol.8, p.847, 2018.

I. Yakavets, H. Lassalle, I. Yankovsky, F. Ingrosso, A. Monari et al., Evaluation of temoporfin affinity to ?-cyclodextrins assuming selfaggregation, J. Photochem. Photobiol. Chem, vol.367, pp.13-21, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01861135

I. Yakavets, M. Millard, V. Zorin, H. Lassalle, and L. Bezdetnaya, Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies, J. Controlled Release, vol.304, pp.268-287, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02179885

I. V. Yakavets, I. V. Yankovsky, I. I. Khludeyev, H. P. Lassalle, L. N. Bezdetnaya et al., Optical Methods for the Analysis of the Temoporfin Photosensitizer References Distribution Between Serum Proteins and Methyl-?-Cyclodextrin Nanocarriers in Blood Serum, J. Appl. Spectrosc, vol.84, pp.1030-1036, 2018.

I. Yankovsky, E. Bastien, I. Yakavets, I. Khludeyev, H. Lassalle et al., Inclusion complexation with ?-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.91, pp.172-182, 2016.

S. W. Young, K. W. Woodburn, M. Wright, T. D. Mody, Q. Fan et al., Lutetium Texaphyrin (PCI-0123): A Near-Infrared, Water-Soluble Photosensitizer, Photochem. Photobiol, vol.63, pp.892-897, 1996.

C. M. Yow, J. Y. Chen, N. K. Mak, N. H. Cheung, and A. W. Leung, Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative, Cancer Lett, vol.157, pp.123-131, 2000.

R. Zappacosta, B. Cornelio, S. Pilato, G. Siani, F. Estour et al., Effect of the Incorporation of Functionalized Cyclodextrins in the Liposomal Bilayer, Molecules, vol.24, p.1387, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02330479

J. Zhang, C. Jiang, J. P. Figueiró-longo, R. B. Azevedo, H. Zhang et al., An updated overview on the development of new photosensitizers for anticancer photodynamic therapy, Acta Pharm. Sin. B, vol.8, pp.137-146, 2018.

Q. Zhu, T. Guo, D. Xia, X. Li, C. Zhu et al.,

, Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration, J. Pharm. Pharmacol, vol.65, pp.1107-1117

R. Zidovetzki and I. Levitan, Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies, Biochim. Biophys. Acta, vol.1768, pp.1311-1324, 2007.

, SCIENTIFIC OUTPUT ARTICLES IN PEER-REVIEWED JOURNALS

I. Yakavets, M. Millard, V. Zorin, H. Lassalle, and L. Bezdetnaya, Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies, J Control Release, vol.304, pp.268-287, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02179885

I. Yakavets, S. Jenard, A. Francois, Y. Maklygina, V. Loschenov et al., Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening, J Clin Med, vol.8, issue.10, p.1686, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02418797

T. Mangeolle, I. Yakavets, N. Lequeux, T. Pons, L. Bezdetnaya et al., The targeting ability of fluorescent quantum dots to the folate receptor rich tumors, Photodiagn. Photodyn, vol.26, pp.150-156, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02266463

Y. Maklygina, I. Romanishkin, A. Ryabova, I. Yakavets, L. Bolotina et al., Investigation of the properties of a three-dimensional cell tumor model, Bulletin of RSMU, vol.6, pp.14-20, 2018.

M. Millard, I. Yakavets, M. Piffoux, A. Brun, F. Gazeau et al., mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors, Drug Deliv, vol.25, issue.1, pp.1790-1801, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01996795

I. Yakavets, H. Lassalle, D. Scheglmann, A. Wiehe, V. Zorin et al., Temoporfinin-cyclodextrin-in-liposome -a new approach for anticancer drug delivery: the optimization of composition, Nanomaterials, vol.8, issue.10, pp.847-861, 2018.

T. Mangeolle, I. Yakavets, S. Marchal, T. Pons, L. Bezdetnaya et al., Fluorescent nanoparticles for the guided surgery of ovarian peritoneal carcinomatosis, Nanomaterials, vol.8, pp.572-592, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01860308

I. Yakavets, H. P. Lassalle, I. Yankovsky, F. Ingrosso, A. Monari et al., Evaluation of temoporfin affinity to ?-cyclodextrins assuming self-aggregation, J Photochem Photobiol A, vol.367, pp.13-21, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01861135

I. Yakavets, I. Yankovsky, I. Khludeyev, L. Bezdetnaya, and V. Zorin, Optical Methods for the Analysis of the Temoprofin Photosensitizer Distribution Between Serum Proteins and Methyl?-Cyclodextrin Nanocarriers in Blood Serum, J Appl Spectrosc, vol.84, pp.1030-1036, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01861165

I. Yakavets, I. Yankovsky, M. Millard, L. Lamy, H. Lassalle et al., The alteration of temoporfin distribution in multicellular tumor spheroids by ?cyclodextrins, Int Journal Pharm, vol.529, pp.568-575, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01726347

M. Millard, I. Yakavets, V. Zorin, A. Kulmukhamedova, S. Marchal et al., Drug delivery to solid tumors: The predictive value of the multicellular tumor spheroid model for nanomedicine screening, Int J Nanomed, vol.12, pp.7993-8007, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01660398

D. Farrakhova, I. Yakavets, V. Loschenov, L. Bolotine, and V. Zorin, Investigation of chlorin photosensitizers distribution in monolayer and spheroid cell cultures, Biomedical Photonics, vol.6, issue.2, pp.4-11, 2017.

I. Yakavets, I. Yankovsky, L. Bezdetnaya, and V. Zorin, Soret band shape indicates mTHPC distribution between ?-cyclodextrins and serum proteins, Dyes Pigm, vol.137, pp.299-306, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01418967

I. Yankovsky, E. Bastien, I. Yakavets, I. Khludeyev, H. Lassalle et al., Inclusion complexation with ?-cyclodextrin derivatives alters biodistribution and photosensitizing efficacy of meta-tetra(hydroxyphenyl)chlorin, Eur J Pharm Sci, vol.91, pp.172-182, 2016.

. Major-oral-communucations,

I. Yakavets, H. Lassalle, V. Zorin, and L. Bezdetnaya, Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting. 17 th International Photodynamic association World Congress, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01862333

I. Yakavets, H. Lassalle, V. Zorin, and L. Bezdetnaya, Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting, ESP-IUPB World Congress, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01862333

I. Yakavets, M. Millard, H. Lassalle, V. Zorin, and L. Bezdetnaya, Temoporphin-in-Cyclodextrin-in-Liposome nanoparticles for tumor targeting, Pharmaceutics & Novel Drug Delivery Systems, vol.10, p.32, 2018.

I. Yakavets, H. P. Lassalle, L. Bezdetnaya, and V. Zorin, mTHPC-in-cyclodextin-in-liposome nanodelivery system. 11 th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine (CLINAM), vol.230, 2018.

I. Yakavets, H. P. Lassalle, L. Bezdetnaya, and V. Zorin, Optimization of the composition of liposomal-based hybrid nanoparticles for mTHPC delivery. 4 th International conference Current Trends in Cancer Theranostics, vol.74, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01864534

I. Yakavets, V. P. Zorin, H. P. Lassalle, and L. Bezdetnaya, Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting. 2 nd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems, vol.26, pp.4-6, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01862333

I. Yakavets, I. Yankovsky, H. P. Lassalle, L. Bezdetnaya, and V. Zorin, Cyclodextrins as nanodelivery system in mTHPC-PDT. 16 th International Photodynamic Association World Congress, vol.65, 2017.

D. Farrakhova, Y. Maklygina, I. Romanishkin, A. Ryabova, I. Yakavets et al., Investigation of Ce6 accumulation and distribution in cell cultures of head and neck cancers, Optical and Nano-Technologies for Biology and Medicine, pp.23-27, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02404290

M. Millard, I. Yakavets, H. P. Lassalle, M. Piffoux, F. Gazeau et al., Natural nanocarriers-based mTHPC for the photodynamic therapy, International Conference On Nanomedicine And Nanobiotechnology, vol.176, 2018.

M. Millard, I. Yakavets, H. Lassalle, V. Zorin, A. Kulmukhamedova et al., Nanoparticle-based mTHPC delivery in the photodynamic therapy of cancer, International Conference Laser Optics (ICLO), vol.583, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01861050

D. Farrakhova, I. Yakavets, V. Loschenov, L. Bolotine, and V. Zorin, Comparitive accumulation study of chlorin group photosensitizers on monolayer and multicellular tumor spheroids of cell culture, International Conference Laser Optics (ICLO), p.589, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863262

I. Yankovsky, I. Yakavets, H. P. Lassalle, L. Bezdetnaya, and V. Zorin, Alteration of temoporfin pharmacokinetics by ?-cyclodextrin derivatives, Applied Nanotechnology and Nanoscience International Conference -ANNIC 2017, pp.118-120, 2017.

M. Millard, I. Yakavets, S. Marchal, H. Lassalle, and L. Bezdetnaya, Influence of mTHPC liposomal distribution in multicellular spheroid on the photodynamic therapy efficacy, vol.114, 2016.